MRI of Proximal Femur Microarchitecture as a Biomarker of Bone Quality
近端股骨微结构的 MRI 作为骨质量的生物标志物
基本信息
- 批准号:8818488
- 负责人:
- 金额:$ 60.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAccountingAffectAgeAgingAmericanBiological MarkersBone DensityCaringCase-Control StudiesClassificationClinicalClinical ResearchClinical TrialsDetectionDeteriorationDiagnosisDiscriminationDiseaseEffectivenessElementsEnrollmentEpidemicEvaluationFemoral FracturesFemoral Neck FracturesFemurForearm FractureFractureGoalsHealth Care CostsHip FracturesHip region structureImageIndividualInterventionIonizing radiationLocationLogistic RegressionsLongitudinal StudiesMagnetic Resonance ImagingMethodsModelingMonitorNeckNoiseOsteoporosisPathogenesisPatientsPostmenopausePreventionProbabilityRecruitment ActivityReportingResearchResolutionRiskRisk FactorsSignal TransductionSiteSmokingStudy of magneticsSystemic diseaseTestingThickThree-Dimensional ImagingVisionWomanWorld Health OrganizationX-Ray Computed Tomographybonebone massbone qualitybone strengthcase controlclinical careclinical riskcostdetectorfall riskhigh riskimprovedin vivoinsightmortalitynew therapeutic targetnovelosteoporosis with pathological fracturepredictive modelingpreventpublic health relevanceretinal rodstool
项目摘要
DESCRIPTION (provided by applicant): The goal of this study is to use a novel magnetic resonance imaging (MRI) test to determine if assessment of proximal femur microarchitecture has added value as a biomarker of bone quality and hip fracture risk. Hip or proximal femur fracture is the most devastating type of osteoporotic fracture, affecting 300,000 Americans and accounting for $12 billion in healthcare costs annually. There is a critical need for an improved method to assess proximal femur bone quality in vivo. 54% of women who suffer hip fractures are misclassified by dual- energy x-ray absorptiometry as not osteoporotic. And though the FRAX calculator, clinical factors (e.g. fall risk, immobility), and macrostructural hip assessment have proven highly valuable, the detection of subjects at risk for hip fracture remains a challenge. Bone microarchitecture, a key determinant of bone strength included in the disease definition of osteoporosis, has never been studied in the proximal femur in vivo because of a lack of means to assess it. We have achieved a technical breakthrough: using a novel 26 element receive detector (which boosts signal-to-noise ratio), we have successfully imaged individual trabeculae composing proximal femur microarchitecture on a clinical 3 T MRI scanner in vivo. We will now apply this tool in a clinical study. Our specific aims (SA) are to: 1) Determine how proximal femur microarchitecture changes with aging in post- menopausal women without fracture (n = 100). We hypothesize that higher age will correlate with lower femoral neck cortical thickness, trabecular thickness, number, connectivity, plate-to-rod ratio, and lower whole proximal femur stiffness and ultimate strength. 2) Determine how proximal femur microarchitecture is deranged in post-menopausal women with femoral neck fracture (n = 100). We hypothesize that fracture cases will demonstrate lower femoral neck cortical thickness, trabecular thickness, number, connectivity, plate-to-rod ratio, and lower whole proximal femur stiffness and ultimate strength compared to SA1 controls. 3) Determine the added value of microarchitecture, beyond FRAX/known clinical risk factors, for classifying subjects without and with hip fracture. Our main hypothesis is that adding microarchitecture to a baseline logistic regression model containing FRAX and clinical risk factors will improve model accuracy for classification of fracture status. Our secondary hypothesis is that a model of microarchitecture, FRAX, and clinical risk factors will be more accurate for classification of fracture status than a model of macrostructure, FRAX, and clinical risk factors. If successful, this study will: 1) provid new insight into the pathogenesis and means for prevention of hip fracture; and 2) determine whether microarchitectural assessment allows detection of high-risk hip fracture patients who currently escape detection. If validated in a longitudinal study, this MRI test could be used as an
additional research/clinical care tool to determine whether an individual should or should not receive therapy, or be suitable for clinical trial enrollment. It could also be used as a novel too to monitor the effects of different interventions on proximal femur microarchitecture and strength.
描述(申请人提供):这项研究的目标是使用一种新的磁共振成像(MRI)测试来确定股骨近端微结构的评估作为骨质量和髋部骨折风险的生物标记物是否具有附加价值。髋部或股骨近端骨折是最具破坏性的骨质疏松性骨折类型,影响30万美国人,每年造成120亿美元的医疗费用。迫切需要一种改进的方法来评估活体股骨近端的骨质量。在髋部骨折的女性中,54%的人被双能x射线骨密度仪误认为没有骨质疏松。尽管FRAX计算器、临床因素(如跌倒风险、静止)和髋关节宏观结构评估已被证明具有很高的价值,但检测有髋部骨折风险的受试者仍然是一个挑战。骨微结构是骨质疏松症疾病定义中包含的骨强度的关键决定因素,由于缺乏评估它的手段,在活体股骨近端从未进行过研究。我们取得了技术突破:使用新型26元接收探测器(提高信噪比),我们在临床3T磁共振扫描仪上成功地在活体上成像了组成股骨近端微结构的单个小梁。我们现在将把这个工具应用到临床研究中。我们的具体目标(SA)是:1)确定绝经后未骨折妇女(n=100)股骨近端微结构如何随年龄变化。我们假设较高的年龄将与较低的股骨颈皮质厚度、骨小梁厚度、数量、连接性、板棒比以及较低的股骨近端整体刚度和极限强度相关。2)确定绝经后股骨颈骨折患者股骨近端微结构的紊乱情况(n=100)。我们假设骨折病例的股骨颈皮质厚度、骨小梁厚度、数量、连接性、板棒比以及股骨近端整体硬度和极限强度均低于SA1对照组。3)确定微结构的附加值,超越FRAX/已知的临床危险因素,对无髋部骨折和有髋部骨折的受试者进行分类。我们的主要假设是,在包含FRAX和临床危险因素的基线Logistic回归模型中加入微架构将提高骨折状态分类的模型准确性。我们的第二个假设是,微结构、FRAX和临床危险因素模型对骨折状态的分类比宏观结构、FRAX和临床危险因素模型更准确。如果成功,这项研究将:1)为髋部骨折的发病机制和预防方法提供新的见解;2)确定微架构评估是否可以检测目前逃脱检测的高危髋部骨折患者。如果在纵向研究中得到证实,这项MRI测试可以用作
其他研究/临床护理工具,以确定个人是否应该接受治疗,或是否适合临床试验登记。它也可以作为一种新颖的方法来监测不同干预措施对股骨近端微结构和强度的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory Chang其他文献
Gregory Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory Chang', 18)}}的其他基金
MRI of Proximal Femur Bone Quality for Monitoring Short-Term Response to Osteoporosis Therapy
近端股骨骨质量 MRI 用于监测骨质疏松症治疗的短期反应
- 批准号:
9914226 - 财政年份:2019
- 资助金额:
$ 60.58万 - 项目类别:
MRI of Proximal Femur Bone Quality for Monitoring Short-Term Response to Osteoporosis Therapy
近端股骨骨质量 MRI 用于监测骨质疏松症治疗的短期反应
- 批准号:
10394252 - 财政年份:2019
- 资助金额:
$ 60.58万 - 项目类别:
MRI of Proximal Femur Bone Quality for Monitoring Short-Term Response to Osteoporosis Therapy
近端股骨骨质量 MRI 用于监测骨质疏松症治疗的短期反应
- 批准号:
10615628 - 财政年份:2019
- 资助金额:
$ 60.58万 - 项目类别:
Translation of Hip Microarchitectural Assessment Technology to the Clinic to Diagnose Glucocorticoid-Induced Osteoporosis
将髋关节微结构评估技术应用于临床诊断糖皮质激素引起的骨质疏松症
- 批准号:
9759776 - 财政年份:2016
- 资助金额:
$ 60.58万 - 项目类别:
Translation of Hip Microarchitectural Assessment Technology to the Clinic to Diagnose Glucocorticoid-Induced Osteoporosis
将髋关节微结构评估技术应用于临床诊断糖皮质激素引起的骨质疏松症
- 批准号:
9350247 - 财政年份:2016
- 资助金额:
$ 60.58万 - 项目类别:
MRI of Proximal Femur Microarchitecture as a Biomarker of Bone Quality
近端股骨微结构的 MRI 作为骨质量的生物标志物
- 批准号:
9129600 - 财政年份:2014
- 资助金额:
$ 60.58万 - 项目类别:
Osteoarthritis: Identification of Novel Imaging Biomarkers via 23Na/1H MRI at 7 T
骨关节炎:通过 7 T 23Na/1H MRI 鉴定新型成像生物标志物
- 批准号:
8233972 - 财政年份:2011
- 资助金额:
$ 60.58万 - 项目类别:
Osteoarthritis: Identification of Novel Imaging Biomarkers via 23Na/1H MRI at 7 T
骨关节炎:通过 7 T 23Na/1H MRI 鉴定新型成像生物标志物
- 批准号:
8451394 - 财政年份:2011
- 资助金额:
$ 60.58万 - 项目类别:
Osteoarthritis: Identification of Novel Imaging Biomarkers via 23Na/1H MRI at 7 T
骨关节炎:通过 7 T 23Na/1H MRI 鉴定新型成像生物标志物
- 批准号:
8822827 - 财政年份:2011
- 资助金额:
$ 60.58万 - 项目类别:
Osteoarthritis: Identification of Novel Imaging Biomarkers via 23Na/1H MRI at 7 T
骨关节炎:通过 7 T 23Na/1H MRI 鉴定新型成像生物标志物
- 批准号:
8110291 - 财政年份:2011
- 资助金额:
$ 60.58万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 60.58万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别:
Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 60.58万 - 项目类别: